A Comparison of Dosing Regimens of Paricalcitol Capsule for the Treatment of Secondary Hyperparathyroidism in CKD Stages 3 and 4

Publisher： Karger

E-ISSN： 1421-9670|26|1|105-114

ISSN： 0250-8095

Source： American Journal of Nephrology, Vol.26, Iss.1, 2006-04, pp. : 105-114

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Use of Extended-Release Calcifediol to Treat Secondary Hyperparathyroidism in Stages 3 and 4 Chronic Kidney Disease

By  

American Journal of Nephrology, Vol. 44, Iss. 4, 2016-09 ,pp. : 316-325

Karger

Access to resources Recommend Favorite

Paricalcitol Treatment of Secondary Hyperparathyroidism in Hemodialysis Patients on Sevelamer Hydrochloride: Which Dialysate Calcium Concentration to Use?

By  

Blood Purification, Vol. 27, Iss. 2, 2009-01 ,pp. : 182-186

Karger

Access to resources Recommend Favorite

Treatment of Secondary Hyperparathyroidism in Hemodialyzed Patients with High-Dose Calcium Carbonate without Vitamin D3 Supplements

By  

American Journal of Nephrology, Vol. 19, Iss. 3, 1999-06 ,pp. : 428-432

Karger

Access to resources Recommend Favorite

Vitamin D Analogs for the Treatment of Secondary Hyperparathyroidism

By  

Blood Purification, Vol. 20, Iss. 1, 2002-01 ,pp. : 109-112

Karger

Access to resources Recommend Favorite

Effects of Treatment of Secondary Hyperparathyroidism on the Lipid Profile in Patients on Hemodialysis

By  

Blood Purification, Vol. 16, Iss. 1, 1998-02 ,pp. : 22-29

Karger

Access to resources Recommend Favorite